Our initial focus is on eliminating accumulated senescent cells, which are a fundamental mechanism of aging and a driver of many common age-associated diseases.

Over the arc of one’s life, cells divide until they encounter some form of biologic stress, at which point they pull a form of cellular emergency brake causing them to cease dividing—forever.

The result is an accumulation of senescent cells that secrete large quantities of harmful proteins, which cause inflammation, tissue degradation and the production of growth factors that alter the tissue microenvironment, which we believe leads to several age-associated diseases.

UNITY is developing a number of therapies intended to selectively eliminate senescent cells to halt, slow or reverse age-associated disease and restore tissue to a more functionally healthy state, which we believe addresses a root cause of age-associated diseases.

The following contains links to websites owned and operated by third parties. If you use these links you leave our website. These links are provided for your information and convenience only and are not an endorsement by UNITY Biotechnology, Inc. of the content of such linked websites. UNITY has no control of the content of any linked website and is not responsible for these websites or their content or availability. UNITY therefore makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by or the information contained on them.